A Feasibility Study of Confocal Microendoscopy in the Evaluation of Gastrointestinal Neoplasia -Project 1
Stopped early · Early Phase 1
Conditions studied: GERD, Barrett's Esophagus
In brief
The overall objective of this study is to obtain data to evaluate whether high-resolution imaging of the gastrointestinal mucosain vivo can assist clinicians in detecting dysplastic (precancerous) areas. This is an exploratory study of a confocal endoscope designed to evaluate the feasibility of using this FDA-approved device in the endoscopic surveillance of subjects at high-risk for neoplasia in the upper and lower GI tract. The confocal endoscope provides real-time in vivo microscopic images of the mucosa which resemble standard pathology.
Key facts
- Study ID
- NCT01384695
- Run by
- Anandasabapathy, Sharmila, M.D.
- People needed
- 67
- Starts
- 2009-06-01
- Expected to finish
- 2014-02-01
- Last updated by the study team
- 2016-01-12
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- patient 18 years or older
- colonoscopy for screening or surveillance of polyps or disease of colon
- anoscopy because of suspected or known anal dysplasia or neoplasia
You may not qualify if…
- patient unable to provide informed consent
- patient found unfit for standard colonoscopy or anoscopy with biopsies
Where it is running
- Mount Sinai Medical Center — New York, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.